151 related articles for article (PubMed ID: 19930673)
1. Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Jin F; Qu LS; Shen XZ
Diagn Pathol; 2009 Nov; 4():39. PubMed ID: 19930673
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.
Zhang S; Jiang J; Tang W; Liu L
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931
[TBL] [Abstract][Full Text] [Related]
3. Genetic Polymorphism of MTHFR C677T Influences Susceptibility to HBV-Related Hepatocellular Carcinoma in a Chinese Population: a Case-Control Study.
Qiao K; Zhang S; Trieu C; Dai Q; Huo Z; Du Y; Lu W; Hou W
Clin Lab; 2017 Apr; 63(4):787-795. PubMed ID: 28397480
[TBL] [Abstract][Full Text] [Related]
4. A Meta-Analysis: Methylenetetrahydrofolate Reductase C677T Polymorphism in Gastric Cancer Patients Treated with 5-Fu Based Chemotherapy Predicts Serious Hematologic Toxicity but Not Prognosis.
Tang C; Yu S; Jiang H; Li W; Xu X; Cheng X; Peng K; Chen E; Cui Y; Liu T
J Cancer; 2018; 9(6):1057-1066. PubMed ID: 29581785
[TBL] [Abstract][Full Text] [Related]
5. Association of the methylenetetrahydrofolate reductase gene C677T polymorphism with the risk of male infertility: a meta-analysis.
Zhu X; Liu Z; Zhang M; Gong R; Xu Y; Wang B
Ren Fail; 2016; 38(2):185-93. PubMed ID: 26584688
[TBL] [Abstract][Full Text] [Related]
6. Association between the MTHFR C677T polymorphism and gastric cancer susceptibility: A meta-analysis of 5,757 cases and 8,501 controls.
Chen L; Lu N; Zhang BH; Weng LI; Lu J
Oncol Lett; 2015 Aug; 10(2):1159-1165. PubMed ID: 26622644
[TBL] [Abstract][Full Text] [Related]
7. Influence of
Huang Y; Hu Q; Wei Z; Chen L; Luo Y; Li X; Li C
Open Life Sci; 2023; 18(1):20220680. PubMed ID: 37772262
[TBL] [Abstract][Full Text] [Related]
8. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF
Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892
[TBL] [Abstract][Full Text] [Related]
9. C677T polymorphism of methylenetetrahydrofolate reductase may contribute to cervical cancer risk in complete over-dominant model.
Chen H; Zhu J
Med Hypotheses; 2013 May; 80(5):679-83. PubMed ID: 23490201
[TBL] [Abstract][Full Text] [Related]
10. Associations of C677T polymorphism in methylenetetrahydrofolate reductase (MTHFR) gene with male infertility risk: A meta-analysis.
Hong HH; Hu Y; Yu XQ; Zhou L; Lv MQ; Sun Y; Ren WJ; Zhou DX
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():101-109. PubMed ID: 28363185
[TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase gene C677T polymorphism and breast cancer risk: Evidence for genetic susceptibility.
Kumar P; Yadav U; Rai V
Meta Gene; 2015 Dec; 6():72-84. PubMed ID: 26629412
[TBL] [Abstract][Full Text] [Related]
12. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase C677T polymorphism and congenital heart disease: a meta-analysis.
Nie Y; Gu H; Gong J; Wang J; Gong D; Cong X; Chen X; Hu S
Clin Chem Lab Med; 2011 Dec; 49(12):2101-8. PubMed ID: 21793799
[TBL] [Abstract][Full Text] [Related]
14. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
15. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
Abedinzadeh M; Zare-Shehneh M; Neamatzadeh H; Abedinzadeh M; Karami H
Asian Pac J Cancer Prev; 2015; 16(11):4525-30. PubMed ID: 26107198
[TBL] [Abstract][Full Text] [Related]
16. Association between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and essential hypertension: a systematic review and meta-analysis.
Wu YL; Hu CY; Lu SS; Gong FF; Feng F; Qian ZZ; Ding XX; Yang HY; Sun YH
Metabolism; 2014 Dec; 63(12):1503-11. PubMed ID: 25458833
[TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy.
Rai V; Kumar P
Neurol Sci; 2018 Dec; 39(12):2033-2041. PubMed ID: 30267335
[TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase (
Rai V; Kumar P
AIMS Neurosci; 2021; 8(2):212-225. PubMed ID: 33709025
[TBL] [Abstract][Full Text] [Related]
19. Association of C677T polymorphism (rs1801133) in MTHFR gene with depression.
Rai V
Cell Mol Biol (Noisy-le-grand); 2017 Jul; 63(6):60-67. PubMed ID: 28968218
[TBL] [Abstract][Full Text] [Related]
20.
He L; Shen Y
Onco Targets Ther; 2017; 10():227-238. PubMed ID: 28123304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
